Minami Yuko, Matsuno Yoshihiro, Iijima Tatsuo, Morishita Yukio, Onizuka Masataka, Sakakibara Yuzuru, Noguchi Masayuki
Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.
Lung Cancer. 2005 Jun;48(3):339-48. doi: 10.1016/j.lungcan.2004.11.016. Epub 2005 Jan 22.
To reveal useful prognostic factors in cases of small-sized pulmonary adenocarcinoma, we conducted a histological and karyometric analysis of 116 small-sized pulmonary adenocarcinomas measuring less than 2 cm in maximum diameter and four specimens of atypical adenomatous hyperplasia (AAH). The small-sized pulmonary adenocarcinomas were classified by using criteria described previously [Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Lung Cancer 1995:75;2844-52]. There were 99 tumors of replacement-type adenocarcinoma, comprising 11 type A, localized bronchioloalveolar adenocarcinoma (LBAC); 6 type B, LBAC with alveolar collapse; and 82 type C, LBAC with foci of fibroblastic proliferation. The 17 remaining tumors were non-replacement-type adenocarcinomas. Among the potential prognostic factors examined, histological subtype was the most closely correlated with 5-year relapse-free survival rate. Furthermore, in patients with type C adenocarcinomas, a small fibroblastic proliferation (F) to fibrosis area (f) ratio (F-f ratio) (<10%) of the tumor and a small maximum nuclear diameter (Max ND; <13.50 microm) of tumor cells were closely associated with an excellent prognosis. Histological subtypes of type A and B adenocarcinomas, a small F-f ratio, and a small Max ND of type C adenocarcinomas were closely correlated with an excellent prognosis in small-sized adenocarcinoma.
为了揭示小尺寸肺腺癌病例中的有用预后因素,我们对116例最大直径小于2 cm的小尺寸肺腺癌及4例非典型腺瘤样增生(AAH)标本进行了组织学和核测量分析。小尺寸肺腺癌采用先前描述的标准进行分类[Noguchi M, Morikawa A, Kawasaki M等。肺的小腺癌。组织学特征与预后。肺癌1995;75:2844 - 52]。有99例替代型腺癌肿瘤,包括11例A 型局限性细支气管肺泡腺癌(LBAC);6例B型,伴有肺泡塌陷的LBAC;以及82例C型,伴有成纤维细胞增殖灶的LBAC。其余17例肿瘤为非替代型腺癌。在所检查的潜在预后因素中,组织学亚型与5年无复发生存率最密切相关。此外,在C型腺癌患者中,肿瘤的小成纤维细胞增殖(F)与纤维化面积(f)之比(F - f比)(<10%)以及肿瘤细胞的小最大核直径(最大ND;<13.50微米)与良好预后密切相关。A 型和B型腺癌的组织学亚型、小F - f比以及C型腺癌的小最大ND与小尺寸腺癌的良好预后密切相关。